Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus.
暂无分享,去创建一个
J. Derisi | D. Ganem | A. Polson | David Wang
[1] T. Voyno-Yasenetskaya,et al. Constitutive Activation of NF-κB and Secretion of Interleukin-8 Induced by the G Protein-coupled Receptor of Kaposi's Sarcoma-associated Herpesvirus Involve Gα13 and RhoA* , 2001, The Journal of Biological Chemistry.
[2] Hong Li,et al. Human Herpesvirus 8 (HHV-8)-Encoded Cytokines Induce Expression of and Autocrine Signaling by Vascular Endothelial Growth Factor (VEGF) in HHV-8-Infected Primary-Effusion Lymphoma Cell Lines and Mediate VEGF-Independent Antiapoptotic Effects , 2001, Journal of Virology.
[3] M. Collins,et al. The JNK phosphatase M3/6 is inhibited by protein-damaging stress , 2001, Current Biology.
[4] M. Reitz,et al. Activation of NF-κB by the Human Herpesvirus 8 Chemokine Receptor ORF74: Evidence for a Paracrine Model of Kaposi's Sarcoma Pathogenesis , 2001, Journal of Virology.
[5] E. Geras-Raaka,et al. Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Signals through Multiple Pathways in Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[6] P. Murphy,et al. Kaposi’s Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor Constitutively Activates NF-κB and Induces Proinflammatory Cytokine and Chemokine Production Via a C-Terminal Signaling Determinant , 2001, The Journal of Immunology.
[7] M. Pepper. Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[8] V. Imbert,et al. Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB. , 2001, Blood.
[9] M. Corbellino,et al. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. , 2001, The Journal of general virology.
[10] Yudong D. He,et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.
[11] J. Gutkind,et al. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. , 2001, Cancer research.
[12] Yao Wang. The role and regulation of urokinase‐type plasminogen activator receptor gene expression in cancer invasion and metastasis , 2001, Medicinal research reviews.
[13] J. Cyster,et al. Chemokines as regulators of T cell differentiation , 2001, Nature Immunology.
[14] A. Tulpule,et al. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. , 2000, Blood.
[15] T. McKinsey,et al. Transcription factor NF-kappaB regulates inducible CD83 gene expression in activated T lymphocytes. , 2000, Molecular immunology.
[16] J. Gutkind,et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.
[17] G. Dong,et al. Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism , 2000, Oncogene.
[18] P. Lehner,et al. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Ganem,et al. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] Jae U. Jung,et al. Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.
[21] D. Ganem,et al. Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 57 Encodes a Posttranscriptional Regulator with Multiple Distinct Activities , 2000, Journal of Virology.
[22] Tong-Yuan Yang,et al. Transgenic Expression of the Chemokine Receptor Encoded by Human Herpesvirus 8 Induces an Angioproliferative Disease Resembling Kaposi's Sarcoma , 2000, The Journal of experimental medicine.
[23] Jae U. Jung,et al. Identification of the Novel K15 Gene at the Rightmost End of the Kaposi's Sarcoma-Associated Herpesvirus Genome , 2000, Journal of Virology.
[24] K. Alitalo,et al. Current biology of VEGF-B and VEGF-C. , 1999, Current opinion in biotechnology.
[25] R. Ganju,et al. Kaposi's Sarcoma-associated Herpesvirus-encoded G Protein-coupled Receptor Activation of c-Jun Amino-terminal Kinase/Stress-activated Protein Kinase and Lyn Kinase Is Mediated by Related Adhesion Focal Tyrosine Kinase/Proline-rich Tyrosine Kinase 2* , 1999, The Journal of Biological Chemistry.
[26] D. Du,et al. The N Terminus of Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Is Necessary for High Affinity Chemokine Binding but Not for Constitutive Activity* , 1999, The Journal of Biological Chemistry.
[27] E. Nishida,et al. Molecular Cloning and Characterization of a Novel Dual Specificity Phosphatase, MKP-5* , 1999, The Journal of Biological Chemistry.
[28] A. Haase,et al. Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis , 1999, Journal of Virology.
[29] R. Majeti,et al. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Palestine,et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. , 1999, The New England journal of medicine.
[31] M. Mildner,et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[32] P. Moore,et al. Characterization and Cell Cycle Regulation of the Major Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter , 1999, Journal of Virology.
[33] Thomas N. Kledal,et al. Agonists and Inverse Agonists for the Herpesvirus 8-encoded Constitutively Active Seven-transmembrane Oncogene Product, ORF-74* , 1999, The Journal of Biological Chemistry.
[34] E. Geras-Raaka,et al. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. , 1998, The Journal of clinical investigation.
[35] A. Haase,et al. A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Journal of Virology.
[36] C. Boshoff,et al. Kaposi's sarcoma herpesvirus as a new paradigm for virus‐induced oncogenesis , 1998, Current opinion in oncology.
[37] R. Desrosiers,et al. Deregulation of cell growth by the K1 gene of Karposi's sarcoma-associated herpesvirus , 1998, Nature Medicine.
[38] B. Ensoli,et al. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. , 1998, Cytokine & growth factor reviews.
[39] J. Blalock,et al. Molecular Cloning, Sequence Analysis, Expression, and Tissue Distribution of Suppressin, a Novel Suppressor of Cell Cycle Entry* , 1998, The Journal of Biological Chemistry.
[40] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[41] M. Reitz,et al. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. , 1997, Journal of the National Cancer Institute.
[42] T. Schwartz,et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. , 1997, Science.
[43] M Dictor,et al. Human herpesvirus 8 and Kaposi's sarcoma. , 1997, Seminars in cutaneous medicine and surgery.
[44] L. Rainbow,et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen , 1997, Journal of virology.
[45] E. Tschachler,et al. Expression of HHV‐8 latency‐associated T0.7 RNA in spindle cells and endothelial cells of AIDS‐associated, classical and African Kaposi's sarcoma , 1997, International journal of cancer.
[46] A. Waggoner,et al. Stability, specificity and fluorescence brightness of multiply-labeled fluorescent DNA probes. , 1997, Nucleic acids research.
[47] F. Neipel,et al. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? , 1997, Journal of virology.
[48] G. Millot,et al. Characterization of in vitro culture of HIV-negative Kaposi’s sarcoma-derived cells. In vitro responses to alfa interferon , 1997, Archives of Dermatological Research.
[49] G. Hayward,et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6 , 1997, Nature Medicine.
[50] M. Raffeld,et al. Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. , 1997, Virology.
[51] E. Cesarman,et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.
[52] A. Haase,et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.
[53] F. Neipel,et al. Human herpesvirus 8 encodes a homolog of interleukin-6 , 1997, Journal of virology.
[54] E. Tschachler,et al. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. , 1996, The American journal of pathology.
[55] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma , 1996, Journal of virology.
[56] R. Gallo,et al. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[57] D. Noonan,et al. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. , 1996, Research in virology.
[58] J. Norton,et al. B cell early response gene expression coupled to B cell receptor, CD40 and interleukin‐4 receptor co‐stimulation: evidence for a role of the egr‐2/krox20 transcription factor in B cell proliferation , 1996, European journal of immunology.
[59] B. Dörken,et al. Involvement of NAK‐1, the human nur77 homologue, in surface IgM‐mediated apoptosis in Burkitt lymphoma cell line BL41 , 1995, European journal of immunology.
[60] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[61] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[62] J. Ambroziak,et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.
[63] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[64] J. Levy,et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals , 1994, AIDS.
[65] D. Goeddel,et al. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes , 1993, The Journal of experimental medicine.
[66] A. Cerami,et al. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. , 1993, Journal of immunology.
[67] J. Diebold,et al. Interleukin-6 gene expression in Castleman's disease. , 1991, Blood.
[68] T. Hirano,et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[69] J. Rowley,et al. Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[70] G. Wood,et al. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. , 1985, The American journal of pathology.
[71] T. Schall,et al. Human Macrophage Inflammatory Protein cr ( MIP-lc ~ ) and MIPI ~ Chemoklnes Attract Distinct Populations of Lymphocytes , 2003 .
[72] V. Imbert,et al. Ligation of CD11b and CD11c b 2 integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1 a (MIP-1 a ) and MIP-1 b production in primary human monocytes through a pathway dependent on nuclear factor– k B , 2001 .
[73] D. Ganem,et al. The biology of Kaposi's sarcoma. , 2001, Cancer treatment and research.
[74] M. Clauss. Molecular Biology of the VEGF and the VEGF Receptor Family , 2000, Seminars in thrombosis and hemostasis.
[75] N. Matijevic-Aleksic,et al. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis. , 2000, Annals medicus.
[76] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[77] T. Komori,et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. , 1989, Blood.